Aceclosic Tablet 100 mg

Aceclosic Tablet is a non-steroidal anti-inflammatory drug (NSAID) containing 100 mg Aceclofenac. Manufactured by Physic Pharmaceuticals Ltd, it effectively treats osteoarthritis, rheumatoid arthritis, and acute pain conditions. Priced at ৳4.50 per unit, this tablet form medication offers cost-effective relief with a strip price of ৳45.00.

This NSAID inhibits cyclooxygenase enzymes, reducing prostaglandin production to alleviate inflammation. Patients typically take one 200 mg extended-release tablet daily or two 100 mg film-coated tablets. Always consult a physician for personalized Aceclosic Tablet dosage instructions, especially with pre-existing kidney or liver conditions.

Common Aceclosic Tablet side effects include mild indigestion, nausea, and skin rashes. Avoid concurrent use with diuretics, anticoagulants, or methotrexate due to interaction risks. Store in dry conditions away from children. Pregnant/breastfeeding women should use it only if benefits outweigh fetal risks.

As a preferred alternative to Aceclofenac brands, Aceclosic balances efficacy and affordability. Its therapeutic role in musculoskeletal disorders makes it essential in Bangladeshi healthcare. For generic alternatives, explore our Aceclofenac catalog.

Adults: 100 mg twice daily or 200 mg OD (extended-release). Reduce dose in renal/hepatic impairment. Take after meals. Maximum treatment duration should be determined by physician based on condition severity.

Aceclosic is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.

Pregnancy Category D (3rd trimester contraindicated). Avoid during lactation. Potential risk of premature ductus arteriosus closure in fetus.

Monitor BP, renal function in prolonged use. High-risk GI patients need PPIs co-therapy. Avoid in dehydration conditions. Screen for cardiovascular risks before therapy.

Pediatric safety unestablished. Geriatric dose: 50% normal dose. Avoid in severe renal impairment (CrCl <30). Hepatic impairment requires 12-24 hour dosing intervals.